Skip to content

Development of an automated Portable Parisheka device and its comparative efficacy with traditional Parisheka using Dashamoola Kashaya in the management of Amavata (Rheumatoid Arthritis)

Development of an automated portable Parisheka device and a comparative study of its efficacy with traditional Parisheka using Dashamoola Kashaya in Amavata (Rheumatoid Arthritis) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/081295
Enrollment
60
Registered
2025-02-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M058- Other rheumatoid arthritis with rheumatoid factor

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 20 to 60 years, irrespective of gender, presenting with clinical features of Amavata with Paithika characteristics such as Daha and Raga as described in Ayurvedic classics, and having a confirmed diagnosis of Rheumatoid Arthritis fulfilling the EULAR 2010 criteria, will be included. The study will consider RA patients with tenderness and chronicity of less than 5 years or those who are freshly diagnosed. Eligible participants must be suitable for Swedana procedures and should not have taken NSAIDs or short-acting steroids for the past 1 2 weeks. Additionally, patients must be willing to provide informed consent and adhere to the study protocol

Exclusion criteria

Exclusion criteria: Exclusion criteria include patients suffering from paralysis affecting motor function, diagnosed cases of neoplasm of the spine, gout, traumatic arthritis, or pyogenic osteomyelitis. Patients with comorbidities such as cardiac disease, pulmonary tuberculosis, uncontrolled diabetes mellitus, inflammatory bowel disease, malignant hypertension, or renal function impairment, as well as pregnant women and lactating mothers, will not be included. Individuals contraindicated for Swedana procedures or those with severe peripheral artery disease or other significant vascular conditions that could be worsened by Parisheka therapy are also excluded

Design outcomes

Primary

MeasureTime frame
Improvement in pain scores (VAS) and Reduction in inflammatory markers (CRP, ESR) and achievement of Samyak Swedana Lakshana Timepoint: 0 days, 8 days or 15 days or 22 days

Secondary

MeasureTime frame
Patient s and Administrator s responses, Dermalab parameters during Parisheka using the automated portable device versus the traditional method.Timepoint: 0 days, 8 days or 15 days or 22 days

Countries

India

Contacts

Public ContactDr ARUN N K

All India Institute of Ayurveda New Delhi

drprasanthd@gmail.com9895174060

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026